ArticleAnnals of translational medicine2024

Vismodegib as an adjuvant treatment for periorbital basal cell carcinoma: a case report and review of literature.

Sayena Jabbehdari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.